Medplus Health Services Ltd has received NCLT approval for the merger with its subsidiary MHS Pharmaceuticals, with MHS having a turnover of Rs. 7.22 million vs Medpluss Rs. 4743.23 million standalone and Rs. 56,648.63 million consolidated for FY 2023-24.